Pre-order Enquiry
Request Free Sample
Global Pharma and Health Care Market Size, Status and Forecast 2021-2027
SKU ID : QYR-18673100 | Publishing Date : 01-Jul-2021 | No. of pages : 127
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Pharma and Health Care Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma and Health Care Market Size Growth Rate by Format: 2016 VS 2021 VS 2027
1.2.2 Bottle
1.2.3 Blister
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharma and Health Care Market Share by Prescription: 2016 VS 2021 VS 2027
1.3.2 OTC Drugs
1.3.3 Prescription Drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharma and Health Care Market Perspective (2016-2027)
2.2 Pharma and Health Care Growth Trends by Regions
2.2.1 Pharma and Health Care Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharma and Health Care Historic Market Share by Regions (2016-2021)
2.2.3 Pharma and Health Care Forecasted Market Size by Regions (2022-2027)
2.3 Pharma and Health Care Industry Dynamic
2.3.1 Pharma and Health Care Market Trends
2.3.2 Pharma and Health Care Market Drivers
2.3.3 Pharma and Health Care Market Challenges
2.3.4 Pharma and Health Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma and Health Care Players by Revenue
3.1.1 Global Top Pharma and Health Care Players by Revenue (2016-2021)
3.1.2 Global Pharma and Health Care Revenue Market Share by Players (2016-2021)
3.2 Global Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharma and Health Care Revenue
3.4 Global Pharma and Health Care Market Concentration Ratio
3.4.1 Global Pharma and Health Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma and Health Care Revenue in 2020
3.5 Pharma and Health Care Key Players Head office and Area Served
3.6 Key Players Pharma and Health Care Product Solution and Service
3.7 Date of Enter into Pharma and Health Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma and Health Care Breakdown Data by Format
4.1 Global Pharma and Health Care Historic Market Size by Format (2016-2021)
4.2 Global Pharma and Health Care Forecasted Market Size by Format (2022-2027)
5 Pharma and Health Care Breakdown Data by Prescription
5.1 Global Pharma and Health Care Historic Market Size by Prescription (2016-2021)
5.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2022-2027)
6 North America
6.1 North America Pharma and Health Care Market Size (2016-2027)
6.2 North America Pharma and Health Care Market Size by Format
6.2.1 North America Pharma and Health Care Market Size by Format (2016-2021)
6.2.2 North America Pharma and Health Care Market Size by Format (2022-2027)
6.2.3 North America Pharma and Health Care Market Size by Format (2016-2027)
6.3 North America Pharma and Health Care Market Size by Prescription
6.3.1 North America Pharma and Health Care Market Size by Prescription (2016-2021)
6.3.2 North America Pharma and Health Care Market Size by Prescription (2022-2027)
6.3.3 North America Pharma and Health Care Market Size by Prescription (2016-2027)
6.4 North America Pharma and Health Care Market Size by Country
6.4.1 North America Pharma and Health Care Market Size by Country (2016-2021)
6.4.2 North America Pharma and Health Care Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharma and Health Care Market Size (2016-2027)
7.2 Europe Pharma and Health Care Market Size by Format
7.2.1 Europe Pharma and Health Care Market Size by Format (2016-2021)
7.2.2 Europe Pharma and Health Care Market Size by Format (2022-2027)
7.2.3 Europe Pharma and Health Care Market Size by Format (2016-2027)
7.3 Europe Pharma and Health Care Market Size by Prescription
7.3.1 Europe Pharma and Health Care Market Size by Prescription (2016-2021)
7.3.2 Europe Pharma and Health Care Market Size by Prescription (2022-2027)
7.3.3 Europe Pharma and Health Care Market Size by Prescription (2016-2027)
7.4 Europe Pharma and Health Care Market Size by Country
7.4.1 Europe Pharma and Health Care Market Size by Country (2016-2021)
7.4.2 Europe Pharma and Health Care Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharma and Health Care Market Size (2016-2027)
8.2 Asia-Pacific Pharma and Health Care Market Size by Format
8.2.1 Asia-Pacific Pharma and Health Care Market Size by Format (2016-2021)
8.2.2 Asia-Pacific Pharma and Health Care Market Size by Format (2022-2027)
8.2.3 Asia-Pacific Pharma and Health Care Market Size by Format (2016-2027)
8.3 Asia-Pacific Pharma and Health Care Market Size by Prescription
8.3.1 Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2021)
8.3.2 Asia-Pacific Pharma and Health Care Market Size by Prescription (2022-2027)
8.3.3 Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2027)
8.4 Asia-Pacific Pharma and Health Care Market Size by Region
8.4.1 Asia-Pacific Pharma and Health Care Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharma and Health Care Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharma and Health Care Market Size (2016-2027)
9.2 Latin America Pharma and Health Care Market Size by Format
9.2.1 Latin America Pharma and Health Care Market Size by Format (2016-2021)
9.2.2 Latin America Pharma and Health Care Market Size by Format (2022-2027)
9.2.3 Latin America Pharma and Health Care Market Size by Format (2016-2027)
9.3 Latin America Pharma and Health Care Market Size by Prescription
9.3.1 Latin America Pharma and Health Care Market Size by Prescription (2016-2021)
9.3.2 Latin America Pharma and Health Care Market Size by Prescription (2022-2027)
9.3.3 Latin America Pharma and Health Care Market Size by Prescription (2016-2027)
9.4 Latin America Pharma and Health Care Market Size by Country
9.4.1 Latin America Pharma and Health Care Market Size by Country (2016-2021)
9.4.2 Latin America Pharma and Health Care Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma and Health Care Market Size (2016-2027)
10.2 Middle East & Africa Pharma and Health Care Market Size by Format
10.2.1 Middle East & Africa Pharma and Health Care Market Size by Format (2016-2021)
10.2.2 Middle East & Africa Pharma and Health Care Market Size by Format (2022-2027)
10.2.3 Middle East & Africa Pharma and Health Care Market Size by Format (2016-2027)
10.3 Middle East & Africa Pharma and Health Care Market Size by Prescription
10.3.1 Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2021)
10.3.2 Middle East & Africa Pharma and Health Care Market Size by Prescription (2022-2027)
10.3.3 Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2027)
10.4 Middle East & Africa Pharma and Health Care Market Size by Country
10.4.1 Middle East & Africa Pharma and Health Care Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharma and Health Care Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Pharma and Health Care Introduction
11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Pharma and Health Care Introduction
11.2.4 Novartis Revenue in Pharma and Health Care Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Pharma and Health Care Introduction
11.3.4 Roche Revenue in Pharma and Health Care Business (2016-2021)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Pharma and Health Care Introduction
11.4.4 AbbVie Revenue in Pharma and Health Care Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Pharma and Health Care Introduction
11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2016-2021)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction
11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2016-2021)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pharma and Health Care Introduction
11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharma and Health Care Introduction
11.8.4 Pfizer Revenue in Pharma and Health Care Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Pharma and Health Care Introduction
11.9.4 Sanofi Revenue in Pharma and Health Care Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharma and Health Care Introduction
11.10.4 Takeda Revenue in Pharma and Health Care Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Pharma and Health Care Introduction
11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Pharma and Health Care Introduction
11.12.4 Bayer Revenue in Pharma and Health Care Business (2016-2021)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Details
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction
11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2016-2021)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Pharma and Health Care Introduction
11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2016-2021)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Pharma and Health Care Introduction
11.15.4 Amgen Revenue in Pharma and Health Care Business (2016-2021)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Pharma and Health Care Introduction
11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2016-2021)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Details
11.17.2 Teva Business Overview
11.17.3 Teva Pharma and Health Care Introduction
11.17.4 Teva Revenue in Pharma and Health Care Business (2016-2021)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction
11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2016-2021)
11.18.5 Boehringer Ingelheim Recent Development
11.18 Biogen
.1 Biogen Company Details
.2 Biogen Business Overview
.3 Biogen Pharma and Health Care Introduction
.4 Biogen Revenue in Pharma and Health Care Business (2016-2021)
.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Details
11.20.2 Astellas Business Overview
11.20.3 Astellas Pharma and Health Care Introduction
11.20.4 Astellas Revenue in Pharma and Health Care Business (2016-2021)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Pharma and Health Care Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bottle
Table 3. Key Players of Blister
Table 4. Key Players of Others
Table 5. Global Pharma and Health Care Market Size Growth by Prescription (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharma and Health Care Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharma and Health Care Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pharma and Health Care Market Share by Regions (2016-2021)
Table 9. Global Pharma and Health Care Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pharma and Health Care Market Share by Regions (2022-2027)
Table 11. Pharma and Health Care Market Trends
Table 12. Pharma and Health Care Market Drivers
Table 13. Pharma and Health Care Market Challenges
Table 14. Pharma and Health Care Market Restraints
Table 15. Global Pharma and Health Care Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pharma and Health Care Market Share by Players (2016-2021)
Table 17. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Health Care as of 2020)
Table 18. Ranking of Global Top Pharma and Health Care Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pharma and Health Care Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharma and Health Care Product Solution and Service
Table 22. Date of Enter into Pharma and Health Care Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 25. Global Pharma and Health Care Revenue Market Share by Format (2016-2021)
Table 26. Global Pharma and Health Care Forecasted Market Size by Format (2022-2027) (US$ Million)
Table 27. Global Pharma and Health Care Revenue Market Share by Format (2022-2027) & (US$ Million)
Table 28. Global Pharma and Health Care Market Size Share by Prescription (2016-2021) & (US$ Million)
Table 29. Global Pharma and Health Care Revenue Market Share by Prescription (2016-2021)
Table 30. Global Pharma and Health Care Forecasted Market Size by Prescription (2022-2027) (US$ Million)
Table 31. Global Pharma and Health Care Revenue Market Share by Prescription (2022-2027) & (US$ Million)
Table 32. North America Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 33. North America Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million)
Table 34. North America Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million)
Table 35. North America Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million)
Table 36. North America Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 39. Europe Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million)
Table 40. Europe Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million)
Table 41. Europe Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million)
Table 42. Europe Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharma and Health Care Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pharma and Health Care Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 51. Latin America Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million)
Table 52. Latin America Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million)
Table 53. Latin America Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million)
Table 54. Latin America Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pharma and Health Care Market Size by Format (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Pharma and Health Care Product
Table 65. Johnson & Johnson Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Pharma and Health Care Product
Table 70. Novartis Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Pharma and Health Care Product
Table 75. Roche Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Pharma and Health Care Product
Table 80. AbbVie Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Merck & Co. Company Details
Table 83. Merck & Co. Business Overview
Table 84. Merck & Co. Pharma and Health Care Product
Table 85. Merck & Co. Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 86. Merck & Co. Recent Development
Table 87. Bristol Myers Squibb Company Details
Table 88. Bristol Myers Squibb Business Overview
Table 89. Bristol Myers Squibb Pharma and Health Care Product
Table 90. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 91. Bristol Myers Squibb Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Pharma and Health Care Product
Table 95. GlaxoSmithKline Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Pharma and Health Care Product
Table 104. Sanofi Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Takeda Company Details
Table 107. Takeda Business Overview
Table 108. Takeda Pharma and Health Care Product
Table 109. Takeda Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 110. Takeda Recent Development
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Pharma and Health Care Product
Table 114. AstraZeneca Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 115. AstraZeneca Recent Development
Table 116. Bayer Company Details
Table 117. Bayer Business Overview
Table 118. Bayer Pharma and Health Care Product
Table 119. Bayer Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 120. Bayer Recent Development
Table 121. Eli Lilly & Co. Company Details
Table 122. Eli Lilly & Co. Business Overview
Table 123. Eli Lilly & Co. Pharma and Health Care Product
Table 124. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 125. Eli Lilly & Co. Recent Development
Table 126. Gilead Sciences Company Details
Table 127. Gilead Sciences Business Overview
Table 128. Gilead Sciences Pharma and Health Care Product
Table 129. Gilead Sciences Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 130. Gilead Sciences Recent Development
Table 131. Amgen Company Details
Table 132. Amgen Business Overview
Table 133. Amgen Pharma and Health Care Product
Table 134. Amgen Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 135. Amgen Recent Development
Table 136. Novo Nordisk Company Details
Table 137. Novo Nordisk Business Overview
Table 138. Novo Nordisk Pharma and Health Care Product
Table 139. Novo Nordisk Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 140. Novo Nordisk Recent Development
Table 141. Teva Company Details
Table 142. Teva Business Overview
Table 143. Teva Pharma and Health Care Product
Table 144. Teva Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 145. Teva Recent Development
Table 146. Boehringer Ingelheim Company Details
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Pharma and Health Care Product
Table 149. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 150. Boehringer Ingelheim Recent Development
Table 151. Biogen Company Details
Table 152. Biogen Business Overview
Table 153. Biogen Pharma and Health Care Product
Table 154. Biogen Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 155. Biogen Recent Development
Table 156. Astellas Company Details
Table 157. Astellas Business Overview
Table 158. Astellas Pharma and Health Care Product
Table 159. Astellas Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million)
Table 160. Astellas Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharma and Health Care Market Share by Format: 2020 VS 2027
Figure 2. Bottle Features
Figure 3. Blister Features
Figure 4. Others Features
Figure 5. Global Pharma and Health Care Market Share by Prescription: 2020 VS 2027
Figure 6. OTC Drugs Case Studies
Figure 7. Prescription Drugs Case Studies
Figure 8. Pharma and Health Care Report Years Considered
Figure 9. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharma and Health Care Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharma and Health Care Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharma and Health Care Market Share by Regions (2022-2027)
Figure 13. Global Pharma and Health Care Market Share by Players in 2020
Figure 14. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Health Care as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharma and Health Care Revenue in 2020
Figure 16. Global Pharma and Health Care Revenue Market Share by Format (2016-2021)
Figure 17. Global Pharma and Health Care Revenue Market Share by Format (2022-2027)
Figure 18. North America Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharma and Health Care Market Share by Format (2016-2027)
Figure 20. North America Pharma and Health Care Market Share by Prescription (2016-2027)
Figure 21. North America Pharma and Health Care Market Share by Country (2016-2027)
Figure 22. United States Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharma and Health Care Market Share by Format (2016-2027)
Figure 26. Europe Pharma and Health Care Market Share by Prescription (2016-2027)
Figure 27. Europe Pharma and Health Care Market Share by Country (2016-2027)
Figure 28. Germany Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharma and Health Care Market Share by Format (2016-2027)
Figure 36. Asia-Pacific Pharma and Health Care Market Share by Prescription (2016-2027)
Figure 37. Asia-Pacific Pharma and Health Care Market Share by Region (2016-2027)
Figure 38. China Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharma and Health Care Market Share by Format (2016-2027)
Figure 46. Latin America Pharma and Health Care Market Share by Prescription (2016-2027)
Figure 47. Latin America Pharma and Health Care Market Share by Country (2016-2027)
Figure 48. Mexico Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharma and Health Care Market Share by Format (2016-2027)
Figure 52. Middle East & Africa Pharma and Health Care Market Share by Prescription (2016-2027)
Figure 53. Middle East & Africa Pharma and Health Care Market Share by Country (2016-2027)
Figure 54. Turkey Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 60. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 61. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 62. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 69. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 71. Amgen Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 72. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 73. Teva Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 74. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 75. Biogen Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 76. Astellas Revenue Growth Rate in Pharma and Health Care Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Keyplayers in Global Pharma and Health Care Market Size, Status and Forecast 2021-2027
Johnson & JohnsonNovartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
